no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
An epidemiologic survey of cardiovascular disease in women taking oral contraceptives
|
Thorogood, Margaret |
|
1990 |
163 |
1P2 |
p. 274-281 8 p. |
article |
2 |
Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984
|
Hirvonen, Erkki |
|
1990 |
163 |
1P2 |
p. 281-284 4 p. |
article |
3 |
Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease
|
Gaspard, Ulysse J. |
|
1990 |
163 |
1P2 |
p. 334-343 10 p. |
article |
4 |
Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: Relation to the development of cardiovascular disease
|
Kelleher, Cecily C. |
|
1990 |
163 |
1P2 |
p. 392-395 4 p. |
article |
5 |
Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets
|
Daly, Leisha |
|
1990 |
163 |
1P2 |
p. 430-437 8 p. |
article |
6 |
Disorders of the hemostatic system and the risk of the development of thrombotic and cardiovascular diseases: Limitations of laboratory diagnosis
|
Kluft, Cornelis |
|
1990 |
163 |
1P2 |
p. 305-312 8 p. |
article |
7 |
Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: A one-year randomized, prospective, comparative trial
|
Jandrain, Bernard J. |
|
1990 |
163 |
1P2 |
p. 378-381 4 p. |
article |
8 |
Effects of long-term gestodene-containing oral contraceptive administration on hemostasis
|
Abbate, Rosanna |
|
1990 |
163 |
1P2 |
p. 424-429 6 p. |
article |
9 |
Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
|
Jespersen, Jørgen |
|
1990 |
163 |
1P2 |
p. 396-403 8 p. |
article |
10 |
Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: The Telecom Study
|
Simon, Dominique |
|
1990 |
163 |
1P2 |
p. 382-387 6 p. |
article |
11 |
Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyI estradiol on lipid metabolism in comparison with two levonorgestrel preparations
|
Kloosterboer, Helenius J. |
|
1990 |
163 |
1P2 |
p. 370-373 4 p. |
article |
12 |
Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen
|
Gram, Jørgen |
|
1990 |
163 |
1P2 |
p. 438-442 5 p. |
article |
13 |
Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism
|
Gevers Leuven, Jan A. |
|
1990 |
163 |
1P2 |
p. 358-362 5 p. |
article |
14 |
Hemostasis profile in women taking low-dose oral contraceptives
|
David, J.L. |
|
1990 |
163 |
1P2 |
p. 420-423 4 p. |
article |
15 |
Impairment of glucose tolerance: Mechanism of action and impact on the cardiovascular system
|
Beck-Nielsen, Henning |
|
1990 |
163 |
1P2 |
p. 292-295 4 p. |
article |
16 |
Influence of oral contraceptives on coagulation tests in native blood and plasma
|
Kunz, Friedebert |
|
1990 |
163 |
1P2 |
p. 417-420 4 p. |
article |
17 |
Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular disease
|
Juhan-Vague, Irene |
|
1990 |
163 |
1P2 |
p. 313-315 3 p. |
article |
18 |
Introductory remarks
|
Jespersen, Jorgen |
|
1990 |
163 |
1P2 |
p. 273- 1 p. |
article |
19 |
Low-dose oral contraceptives and carbohydrate metabolism
|
Godsland, Ian F. |
|
1990 |
163 |
1P2 |
p. 348-353 6 p. |
article |
20 |
Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular level
|
Skouby, Sven O. |
|
1990 |
163 |
1P2 |
p. 343-348 6 p. |
article |
21 |
Metabolic changes during the normal menstrual cycle: A longitudinal study
|
Lebech, Anne-Mette |
|
1990 |
163 |
1P2 |
p. 414-416 3 p. |
article |
22 |
Metabolic changes during treatment with two different progestogens
|
Refn, Hanne |
|
1990 |
163 |
1P2 |
p. 374-377 4 p. |
article |
23 |
Oral contraceptives in risk groups: Exclusion or monitoring?
|
Guillebaud, John |
|
1990 |
163 |
1P2 |
p. 443-446 4 p. |
article |
24 |
Past use of oral contraceptives and cardiovascular disease: A meta-analysis in the context of the Nurses’ Health Study
|
Stampfer, Meir J. |
|
1990 |
163 |
1P2 |
p. 285-291 7 p. |
article |
25 |
Pharmacokinetics of gestagens: Some problems
|
Fotherby, K. |
|
1990 |
163 |
1P2 |
p. 323-328 6 p. |
article |
26 |
Protein binding of active ingredients and comparison of serum ethinyl estradiol sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ ethinyl estradiol (Femovan) or a combination of desogestrel/ ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives
|
Hümpel, Michael |
|
1990 |
163 |
1P2 |
p. 329-333 5 p. |
article |
27 |
Role of plasma lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects
|
Tikkanen, Matti J. |
|
1990 |
163 |
1P2 |
p. 296-304 9 p. |
article |
28 |
Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications
|
Goldzieher, Joseph W. |
|
1990 |
163 |
1P2 |
p. 318-322 5 p. |
article |
29 |
Some aspects of the relationship between oral contraceptives, lipid abnormalities, and cardiovascular disease
|
Samsioe, Göran |
|
1990 |
163 |
1P2 |
p. 354-358 5 p. |
article |
30 |
Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables
|
Kooistra, Teake |
|
1990 |
163 |
1P2 |
p. 404-413 10 p. |
article |
31 |
The clinical relevance of oral contraceptive pill-induced plasma lipid changes: Facts and fiction
|
Hoppe, Gundolf |
|
1990 |
163 |
1P2 |
p. 388-391 4 p. |
article |
32 |
Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives
|
Kuhl, Herbert |
|
1990 |
163 |
1P2 |
p. 363-369 7 p. |
article |
33 |
Why do we need pharmacokinetic studies?
|
Hvidberg, Eigill F. |
|
1990 |
163 |
1P2 |
p. 316-318 3 p. |
article |